TY - JOUR
T1 - Critical overview
T2 - Adverse cutaneous reactions to psychotropic medications
AU - Kimyai-Asadi, Arash
AU - Harris, James C.
AU - Nousari, Hossein C.
PY - 1999/10
Y1 - 1999/10
N2 - Background: Adverse cutaneous reactions (ACRs) are common, potentially life-threatening or symptomatically and cosmetically unappealing side effects of psychotropic drugs. Data Sources: A MEDLINE search of the literature was employed to cite the association of various psychotropic drugs with specific cutaneous reactions. Data Synthesis: In addition to the common exanthematous eruption, we explore several serious reactions including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria, angioedema, anaphylaxis, hypersensitivity syndrome, hypersensitivity vasculitis, erythroderma, and drug-induced lupus erythematosus. Other side effects such as alopecia, pigmentary disorders, photosensitivity, lichenoid lesions, fixed drug eruptions, and psoriasiform, acneiform, and seborrheic eruptions are discussed. Attention is paid to the morphology and distribution, systemic findings, diagnosis, and treatment of these conditions. Conclusion: Awareness of ACRs will allow psychiatrists to deter their continuation or recurrence, educate patients who have them, and diagnose serious instances of them.
AB - Background: Adverse cutaneous reactions (ACRs) are common, potentially life-threatening or symptomatically and cosmetically unappealing side effects of psychotropic drugs. Data Sources: A MEDLINE search of the literature was employed to cite the association of various psychotropic drugs with specific cutaneous reactions. Data Synthesis: In addition to the common exanthematous eruption, we explore several serious reactions including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria, angioedema, anaphylaxis, hypersensitivity syndrome, hypersensitivity vasculitis, erythroderma, and drug-induced lupus erythematosus. Other side effects such as alopecia, pigmentary disorders, photosensitivity, lichenoid lesions, fixed drug eruptions, and psoriasiform, acneiform, and seborrheic eruptions are discussed. Attention is paid to the morphology and distribution, systemic findings, diagnosis, and treatment of these conditions. Conclusion: Awareness of ACRs will allow psychiatrists to deter their continuation or recurrence, educate patients who have them, and diagnose serious instances of them.
UR - http://www.scopus.com/inward/record.url?scp=0032696476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032696476&partnerID=8YFLogxK
U2 - 10.4088/JCP.v60n1010
DO - 10.4088/JCP.v60n1010
M3 - Article
C2 - 10549695
AN - SCOPUS:0032696476
SN - 0160-6689
VL - 60
SP - 714
EP - 725
JO - Journal of Clinical Psychiatry
JF - Journal of Clinical Psychiatry
IS - 10
ER -